生命科学资讯

Illumina (ILMN): Assessing Valuation After a Quiet Share Price Rebound - Yahoo! Finance Canada

Illumina (ILMN): Reassessing Valuation After Recent Share Price Momentum From a Low Base - simplywall.st

‘Market’s thinking is backwards’: FDA’s 1-trial approval plan would boost R&D spend, Jefferies says

FDA panel votes against J&J's novel shunt implant for heart failure

Michel Lagarde Sells 32,000 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat

RFK Jr.’s hand-picked panel questions childhood vaccine schedule

Lagarde of Thermo Fisher sells $12.4m in stock - Investing.com

Will Thermo Fisher's Asia Bioprocessing Tri-Hub Expansion Reshape Thermo Fisher Scientific's (TMO) Narrative? - simplywall.st

Natera buys Foresight Diagnostics in cancer testing deal worth up to $450M

Encoded deciphers path to pivotal trial with phase 1/2 Dravet gene therapy data

'Unprecedented turmoil' engulfing FDA threatens public health: mRNA coalition speaks out

How AI and real-world evidence are powering smarter decisions across the drug and device development lifecycle

A New Era in Parkinson’s: Solengepras Leads the Shift Beyond Dopamine

Bristol Myers expands Breyanzi approval to marginal zone lymphoma

Thermo Fisher Scientific expands bioprocessing capabilities in India, Korea and Singapore - chemengonline.com

Other news to note for Dec. 5, 2025

Regulatory actions for Dec. 5, 2025

Money raised by biopharma

Biopharma money raised: Jan. 1-Dec. 4, 2025

BioWorld and Nasdaq stock indices